Question

which of the following medications should a pharmacy technician identify as being included in the risk evaluation and mitigation strategies (rems) program? clindamycin (cleocin) tretinoin (retin a) isotretinoin (accutane) doxycycline (oracea)

Explanation:

The Risk Evaluation and Mitigation Strategies (REMS) program includes medications with significant safety risks. Isotretinoin (Accutane) is known to have serious risks like birth defects, so it's part of REMS. Clindamycin, tretinoin (Retin - A), and doxycycline don't have the same level of risks that require REMS inclusion.

Answer:

C. Isotretinoin (Accutane)